Cancer Headlines MELVILLE, N.Y. and SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Nov. 2, 2005--OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) and Genentech, Inc. (NYSE: DNA) announced today that the U.S. Food and Drug Administration (FDA) approved Tarceva(R) (erlotinib) in combination with gemcitabine chemotherapy for the treatment of advanced pancreatic cancer in patients who have not received previous chemotherapy. Tarceva is the first drug in a Phase III trial to have shown a significant improvement in overall survival when added to gemcitabine chemotherapy as initial treatment for pancreatic cancer. Tarceva is a once-daily oral tablet already approved for use in patients with non-small cell lung cancer (NSCLC) whose disease has progressed after one or more courses of chemotherapy. OSI also announced that Roche, its international partner for Tarceva, has submitted a Marketing Authorization Application (MAA) to the European Health Authorities for Tarceva for the treatment of pancreatic cancer.
|
||
|
||
|
||
|
||
|
Colon Cancer Treatment
Aspirin May Prevent Colon Cancer in WomenA recent study showed that taking aspirin could in fact reduce your risk of getting colon cancer. Although the study only involved data taking from a sampling of women, it appears that aspirin may possibly prevent colon cancer, or so they say? Aspirin is over 100-years old and appears to cure lots of things, yet many were shocked to learn of this latest finding, still other completely doubt the study. The study showed that people who already had polyps maybe able to prevent the onset of colon cancer thru regular use of aspirin. The researchers went on to extrapolate that it could help those without polyps from getting one in the first place. Now several articles in major Medical Journals are showing that if you took aspirin for a decade 1-2 per week, it would reduce the risk of colorectal cancer by a large margin over those who did not take aspirin regularly. Some of the researchers in near by fields were not surprised while other totally doubted the findings as hogwash. They are saying that any anti-inflammatory drug may have done the same and would certainly help to keep removed polyps from returning, thus reduce the risk of cancer. The study indicated that 14 aspirins per week or 2 every day would reduce the chances of colon cancer by nearly one-third. Those who took even more are said to reduce colon cancer by over 50 percentiles. Of course taking that many aspirins is not good for you, over use of aspirin can cause bleeding. So although the study appears to be a wash for many belief systems of cancer researchers, the evidence is notable and very telling. All this research is helping us fight some of the more serious forms of cancer killers. Think on this and live strong. "Lance Winslow" - If you have innovative thoughts and unique perspectives, come think with Lance; www.WorldThinkTank.net/wttbbs Article Source: http://EzineArticles.com/
|
